标题
Kinases and Cancer
作者
关键词
-
出版物
Cancers
Volume 10, Issue 3, Pages 63
出版商
MDPI AG
发表日期
2018-03-02
DOI
10.3390/cancers10030063
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancer
- (2018) Yang-Kun Wang et al. Cancer Biomarkers
- Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer
- (2017) Martin Hoffmann et al. INTERNATIONAL JOURNAL OF CANCER
- KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
- (2017) Jonas Cicenas et al. MEDICAL ONCOLOGY
- Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression
- (2017) Daniela Alterio et al. MEDICAL ONCOLOGY
- Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer
- (2017) Chun-wei Xu et al. Thoracic Cancer
- EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients
- (2017) et al. Cancers
- EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo
- (2016) Chenfei Zhou et al. CURRENT CANCER DRUG TARGETS
- The Aurora kinase inhibitors in cancer research and therapy
- (2016) Jonas Cicenas JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multi-kinase inhibitors, AURKs and cancer
- (2016) Jonas Cicenas et al. MEDICAL ONCOLOGY
- The neXtProt knowledgebase on human proteins: 2017 update
- (2016) Pascale Gaudet et al. NUCLEIC ACIDS RESEARCH
- Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program
- (2016) Adrienne L. Morey et al. PATHOLOGY
- EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer
- (2016) Sajid A. Khan et al. PATHOLOGY & ONCOLOGY RESEARCH
- Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients
- (2016) Paola Griseri et al. Oncotarget
- Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion
- (2016) Nakho Chang et al. Oncotarget
- Emerging treatment for advanced lung cancer withEGFRmutation
- (2015) Cengiz Inal et al. EXPERT OPINION ON EMERGING DRUGS
- Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
- (2015) Helen Gharwan et al. Nature Reviews Clinical Oncology
- BRAF V600E mutation-specific antibody: A review
- (2015) Lauren L. Ritterhouse et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis
- (2015) Lin Yan et al. Scientific Reports
- Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
- (2015) Sacha Rothschild Cancers
- Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer
- (2014) Xin-Juan Fan et al. TUMOR BIOLOGY
- Highlights of the Latest Advances in Research on CDK Inhibitors
- (2014) Jonas Cicenas et al. Cancers
- Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients
- (2013) J M Willder et al. BRITISH JOURNAL OF CANCER
- METamplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy
- (2013) Xin An et al. CANCER
- The CDK inhibitors in cancer research and therapy
- (2011) Jonas Cicenas et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Overexpression of EphA2 correlates with epithelial–mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients
- (2011) Futao Hou et al. MEDICAL ONCOLOGY
- Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab
- (2010) Bing-Bing Yang et al. CLINICAL PHARMACOKINETICS
- HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target
- (2010) Chih-Ping Han et al. HISTOPATHOLOGY
- Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
- (2010) Jonas Cicenas et al. Cancers
- Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer
- (2009) De-Yuan Fu et al. HUMAN PATHOLOGY
- Clinical Relevance ofHER2Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer
- (2009) Giuseppe Curigliano et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features
- (2009) Dong Sun Kim et al. LUNG CANCER
- BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- (2008) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started